HILAR CHOLANGIOCARCINOMA
Clinical trials for HILAR CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HILAR CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for HILAR CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink bile duct tumors before surgery
Disease control Recruiting nowThis study tests a new approach for people with a type of bile duct cancer that is difficult to remove with surgery. Participants receive a combination of targeted radiation, immunotherapy (tislelizumab), and chemotherapy before any surgery. The goal is to shrink the tumor enough…
Matched conditions: HILAR CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Jinbo Yue • Aim: Disease control
Last updated May 17, 2026 01:32 UTC
-
Simple blood test could catch deadly bile duct cancers early
Diagnosis Recruiting nowThis study is testing a blood test that looks for DNA changes from cancer cells to detect biliary tract cancers (cancers of the bile ducts and gallbladder) earlier. These cancers are often found late, making them hard to treat. The test aims to improve diagnosis and help doctors …
Matched conditions: HILAR CHOLANGIOCARCINOMA
Sponsor: Yingbin Liu, MD, PhD, FACS • Aim: Diagnosis
Last updated May 17, 2026 01:19 UTC